Alzamend Neuro (ALZN) Property, Plant & Equipment (Net) (2022 - 2026)
Powered by 
Analysis
Alzamend Neuro (ALZN) Property, Plant & Equipment (Net) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.68 Bn | 193.69 Bn | 7.24 Bn | 8.55 Bn |
| 2 | Gilead Sciences | 178.73 Bn | 175.55 Bn | 6.22 Bn | 5.83 Bn |
| 3 | Vertex Pharmaceuticals | 131.05 Bn | 123.20 Bn | 2.84 Bn | 1.67 Bn |
| 4 | Regeneron Pharmaceuticals | 81.79 Bn | 73.80 Bn | 3.93 Bn | 5.46 Bn |
| 5 | Argenx Se | 60.99 Bn | 55.81 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 53.41 Bn | 48.27 Bn | 52.00 Mn | 2.06 Bn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Biogen | 31.72 Bn | 30.43 Bn | 1.96 Bn | 2.99 Bn |
| 9 | Roivant Sciences | 29.53 Bn | 29.53 Bn | 1.16 Mn | 11.32 Mn |
| 10 | Alzamend Neuro | 5.57 Mn | 5.57 Mn | - | 314,866.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 314,866.00 |
| Jan 31, 2026 | 342,551.00 |
| Oct 31, 2025 | 370,236.00 |
| Jul 31, 2025 | 397,921.00 |
| Apr 30, 2025 | 425,606.00 |
| Jan 31, 2025 | 228,291.00 |
| Oct 31, 2024 | 240,976.00 |
| Jul 31, 2024 | 253,661.00 |
| Apr 30, 2024 | 176,346.00 |
| Jan 31, 2024 | 189,031.00 |
| Oct 31, 2023 | 201,716.00 |
| Jul 31, 2023 | 214,401.00 |
| Apr 30, 2023 | 79,843.00 |
| Jan 31, 2023 | 85,166.00 |
| Oct 31, 2022 | 90,489.00 |
| Jul 31, 2022 | 95,812.00 |
| Apr 30, 2022 | 102,909.00 |